ABBOTT LABS/ US0028241000 /
25/07/2024 08:01:03 | Chg. +3.58 | Volume | Bid18:13:47 | Ask18:13:47 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
98.63EUR | +3.77% | 0 Turnover: 0.00 |
98.37Bid Size: 40 | 98.68Ask Size: 40 | 171.67 bill.EUR | - | - |
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer